Micron's Two-Speed Reality: A Fully Booked HBM Franchise Versus a Market Haunted by Chinese Ambitions
Published on 08/04/2026 at 08:31 | Redaktion boerse-global.de
The gap between Micron Technology's order book and its share price has rarely looked wider. At Monday's close of €721.10, the stock sits roughly a third below its June 25 record — a 34.67 percent drawdown that stands in stark contrast to a business environment where memory-chip pricing keeps climbing and high-bandwidth memory capacity is sold out through 2027.
That disconnect is the central tension animating the current debate around the company. The recent sell-off was triggered not by a disappointing earnings report, but by two developments out of China: the initial public offering of rival ChangXin Memory Technologies (CXMT) and reports that Apple is evaluating Chinese-made memory chips. CXMT's expansion plans — including preliminary talks, reported in early August, about a second 12-inch fab in Beijing backed by state-linked investors — have injected a fresh dose of anxiety into a market already prone to cyclical fears.
Yet the bearish narrative glosses over a structural imbalance that arguably favors incumbents. Spot prices for DRAM chips (DDR4 8Gb) rose 14.3 percent month-over-month in July 2026, while 128Gb NAND gained 4.3 percent. For DRAM, that marks the eleventh consecutive month of increases. Analysts estimate that AI-driven demand outstrips supply by a factor of twelve — hardly the setup for a pricing collapse.
Micron's moat is most visible in high-bandwidth memory, the premium segment that powers AI accelerators. The company's HBM production for 2026 is already sold out under fixed-price contracts, and industry reports indicate 2027 capacity is increasingly reserved as well. That visibility extends further out: sixteen long-term supply agreements with major customers guarantee roughly $100 billion in minimum revenue through 2030, many with price floors and take-or-pay clauses — a level of contractual stability the historically volatile memory market has never known.
This is the backdrop against which short sellers are placing their bets. Investor Michael Burry is said to have opened a short position when the stock traded at around $934 — well above current levels. The logic of betting against a company whose core segment is booked through 2027 and whose revenue is contractually secured through the end of the decade looks, to many observers, increasingly fraught.
The demand side of the equation remains robust. Financial institutions project that hyperscaler capital expenditures could surpass $1.2 trillion over the next twelve months. Micron is already capturing that spending: fiscal third-quarter 2026 revenue reached $41.46 billion, up 346 percent year-over-year. Even after the recent correction, the stock is still up 186.04 percent since the start of the year.
The bull case, however, must contend with a more cautious camp. A recent UBS survey found that roughly 60 percent of companies are imposing guardrails on AI spending or shifting toward cheaper open-source models. UBS characterizes this as a "healthy problem" that could ultimately drive more demand for inference compute — but near-term, it signals growing cost consciousness among customers, a headwind to the aggressive pricing of recent quarters.
While hyperscalers tighten their AI budgets, another kind of risk assessment deserves your attention — the one protecting your own workplace. Many employers underestimate the gaps in their safety documentation until an incident exposes them. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards and comply with current regulations before problems arise. Download the free Risk Assessment Toolkit
The bears also point to the risk of a premature turn in the memory cycle. CXMT's expansion remains in its financing phase, but if Chinese capacity comes online faster than expected, it could flood the commodity DRAM market, pressuring Micron's broader portfolio rather than just its HBM franchise. CXMT has publicly targeted a 15 percent market share by 2030.
Technically, the stock is in a delicate spot. It trades 15.6 percent below its 50-day moving average of €854.34, with an annualized 30-day volatility of nearly 110 percent — a measure that underscores how violent swings in both directions remain likely. The relative strength index sits at 43.5, suggesting the stock is neither overbought nor oversold. The 100-day average at €651.98 looms as a key support level.
The near-term trajectory could be decided at the "Future of Memory and Storage Summit" in Santa Clara, scheduled for August 4–6, 2026. Investors will be watching for updates on CXMT's financing talks and the ramp of Micron's HBM4 production. If the 100-day average holds as support, a recovery toward the 50-day level of €854.34 remains plausible. If the summit reveals that competitors are closing the gap faster than anticipated — or that hyperscalers are tempering their 2027 hardware procurement — the pressure on the shares is likely to intensify.
For now, the market is weighing two competing narratives: the threat of Chinese competition and a potential cooling in PC and smartphone demand against the sustained appetite for AI memory. With billions in contracted revenue through 2030 and HBM capacity fully reserved, the evidence tilts toward the latter — but the stock's 674 percent rise from its 52-week low of €93.16 leaves little room for error in either direction. The analyst consensus target of €1,321.51 implies more than 80 percent upside from current levels, yet bridging that gap will require the market to look past the headlines from Beijing and focus on the order book in Boise.
